Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Accounts Payables (2023 - 2025)

Profound Medical (PROF) has 3 years of Accounts Payables data on record, last reported at $1.6 million in Q4 2025.

  • For Q4 2025, Accounts Payables rose 18.68% year-over-year to $1.6 million; the TTM value through Dec 2025 reached $1.6 million, up 18.68%, while the annual FY2025 figure was $1.6 million, 18.68% up from the prior year.
  • Accounts Payables reached $1.6 million in Q4 2025 per PROF's latest filing, up from $717000.0 in the prior quarter.
  • Across five years, Accounts Payables topped out at $1.6 million in Q4 2025 and bottomed at $717000.0 in Q3 2025.
  • Average Accounts Payables over 3 years is $1.1 million, with a median of $998500.0 recorded in 2025.
  • Peak YoY movement for Accounts Payables: soared 52.25% in 2024, then grew 18.68% in 2025.
  • A 3-year view of Accounts Payables shows it stood at $865000.0 in 2023, then skyrocketed by 52.25% to $1.3 million in 2024, then increased by 18.68% to $1.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Accounts Payables were $1.6 million in Q4 2025, $717000.0 in Q3 2025, and $949000.0 in Q2 2025.